TAK-573, an anti-CD38-attenuated interferon alpha (IFNa) fusion protein (Attenukine(tm)), has demonstrated IFNa receptor (IFNAR) pathway modulation in patients with relapsed/refractory multiple myeloma
TAK-573
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: TAK-573, an anti-CD38-attenuated interferon alpha (IFNa) fusion protein (Attenukine(tm)), has demonstrated IFNa receptor (IFNAR) pathway modulation in patients with relapsed/refractory multiple myeloma ### Output: TAK-573